ERIN JAEGER: Open Payments
NPI 1407263486 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 37 payments from 11 companies in 2025. Trend: 2023 $1,049 · 2024 $713 · 2025 $821
Food & beverage: $722Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $207 |
| ABBVIE INC. | 4 | $202 |
| Amgen Inc. | 16 | $143 |
| Janssen Biotech, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Incyte Corporation | 2 | $43 |
| GENZYME CORPORATION | 2 | $43 |
| Boston Scientific Corporation | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
Products named: DUPIXENT, BOTOX, Otezla, TREMFYA, OPZELURA, Rhapsido, WaveWriter Alpha Prime 16, YCANTH.
Industry payments across CA — which companies pay providers there.
